TRIM58 silencing via sh1, sh2 (Figures 3(a)–3(c)), and control vector (Figures 3(d)–3(f)) could significantly enhance the chemoresistance of NSCLC cells to the three chemoagents (P < 0.001 for all comparisons). Here, TRIM58 is linked to non-small cell lung carcinoma.